Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baktrofor-Plus is an herbal phytoconcentrate developed through a collaboration between the Ukrainian company Ekomed and the National Cancer Institute of Ukraine (National Cancer Center). It is formulated as a hydro-alcoholic extract of various medicinal plants and is categorized as a dietary supplement intended for supportive care in patients with neoplasms. The product is designed to enhance the body's natural defenses and provide detoxification, particularly for patients undergoing or recovering from conventional oncological treatments such as chemotherapy or radiation. As a complex botanical mixture, it does not have a single defined molecular mechanism of action; instead, it is believed to work through the synergistic effects of its herbal components to modulate immune function and improve the general physiological resilience of the patient.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Baktrofor-Plus.